STOCK TITAN

Bausch + Lomb Announces Participation at the RBC Capital Markets Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Bausch + Lomb (NYSE/TSX: BLCO) announced that CEO Joseph C. Papa will speak at the RBC Capital Markets Global Healthcare Conference on May 17, 2022, at 9:30 a.m. ET. A live webcast will be accessible on the company's Investor Relations page. Bausch + Lomb is a prominent global eye health company founded in 1853, focusing on a diverse portfolio of over 400 products, including contact lenses and surgical instruments, with operations in nearly 100 countries.

Positive
  • CEO Joseph C. Papa's participation in the RBC Capital Markets Global Healthcare Conference may enhance visibility and investor interest.
  • The company has a comprehensive product portfolio with over 400 offerings, indicating strong market presence.
Negative
  • None.

Insights

Analyzing...

VAUGHAN, ON, May 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the RBC Capital Markets Global Healthcare Conference on May 17, 2022, at 9:30 a.m. ET.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

Investor Contact:                                   

Media Contact:

Arthur Shannon                                         

Lainie Keller

arthur.shannon@bauschhealth.com       

lainie.keller@bauschhealth.com


(908) 927-1198



Allison Ryan                                             

Kristy Marks   

Allison.ryan@bauschhealth.com               

kristy.marks@bausch.com  

(877) 354-3705 (toll free)                           

(908) 927-0683



 

Bausch + Lomb (PRNewsfoto/Bausch + Lomb)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb--announces-participation-at-the-rbc-capital-markets-global-healthcare-conference-301546237.html

SOURCE Bausch + Lomb Corporation

FAQ

When is Bausch + Lomb participating in the RBC Capital Markets Global Healthcare Conference?

Bausch + Lomb is participating on May 17, 2022, at 9:30 a.m. ET.

Who is the CEO of Bausch + Lomb?

Joseph C. Papa is the chairman and CEO of Bausch + Lomb.

Where can I find the webcast for the Bausch + Lomb conference?

The webcast will be available on the Investor Relations page of Bausch + Lomb's website.

What is the stock symbol for Bausch + Lomb?

Bausch + Lomb trades under the ticker symbol BLCO on the NYSE and TSX.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Stock Data

4.06B
40.56M
88.41%
10.27%
0.53%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN